Genomic Health Inc. provided revenue guidance for the fourth quarter and full year ended December 31, 2015. For the fourth quarter 2015, the company anticipates reporting between $73 million and $74 million in revenue, representing an increase of approximately 6% compared to the fourth quarter of 2014, and more than 27,520 tests delivered, an increase of approximately 11% compared to the fourth quarter of 2014.

For the year ended December 31, 2015, the company expects revenue to be between $285 million and $286 million, compared with $275.7 million in 2014, representing an increase of approximately 4%, slightly below the company's 2015 guidance.

For the year 2016, the company is providing initial 2016 revenue guidance between $320 million and $335 million, representing growth of between approximately 12% and 17% compared to 2015.